COPD MORTALITY AND ECONOMIC DEPRIVATION: A GLOBAL ANALYSIS OF LUNG FUNCTION ABNORMALITIES
Main Article Content
Keywords
COPD, spirometric restriction, airflow obstruction, socioeconomic factors, smoking, mortality, lung function, global health.
Abstract
Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality worldwide, often attributed to smoking. However, COPD-related deaths are disproportionately high in low-income countries despite their lower smoking prevalence. Recent research suggests that spirometric restriction, rather than airflow obstruction, may be a stronger predictor of COPD mortality. This study examines the relationship between COPD mortality, lung function impairment, smoking habits, and gross national income (GNI) per capita. Using data from 125 patients collected between December 2020 and December 2024, this study assessed the prevalence of airflow obstruction (FEV1/FVC < LLN) and spirometric restriction (FVC < LLN) and their correlation with national COPD mortality rates. We analyzed associations between lung function, smoking history (pack years), and economic indicators, applying Spearman rank correlation and regression models. Results demonstrated a stronger correlation between COPD mortality and spirometric restriction than with airflow obstruction in both younger (<60 years) and older (≥60 years) age groups. Spirometric restriction was not linked to smoking but was significantly higher in lower-income populations. These findings suggest that while smoking remains the dominant cause of airflow obstruction, spirometric restriction—likely driven by socioeconomic factors such as poor early-life nutrition, environmental pollution, and inadequate healthcare—plays a crucial role in high COPD mortality in disadvantaged regions. Addressing these underlying determinants through improved healthcare access, environmental interventions, and early-life nutritional programs could significantly reduce the global COPD burden. Expanding the focus beyond tobacco control to broader socioeconomic and environmental risk factors is essential for effective COPD prevention and management, particularly in resource-limited settings.
References
2. 2.Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347–65
3. 3.Hooper R, Burney P, Vollmer WM, et al. Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. Eur Respir J 2012;39:1343–53
4. 4.Salvi S, Barnes P. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009;374:733–43
5. 5.Office of Population Censuses and Surveys. Occupational mortality: the Registrar General's decennial supplement for Great Britain, 1979–80, 1982–83, Great Britain. Office of Population Censuses and Surveys London: H M Stationery Office, 1986
6. 6.Barker DJP, Osmond C. Childhood respiratory infection and adult chronic bronchitis in England and Wales. BMJ 1986;293:1271–5
7. 7.Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: role of comorbidities. Eur Respir J 2006;28:1245–57
8. 8.Kannel WB, Hubert H, Lew EA. Vital capacity as a predictor of cardiovascular disease: the Framingham Study. Am Heart J 1983;105:311–15
9. 9.Fried LP, Kronmal RA, Newman AB, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998;279:585–92
10. 10.Burney PGJ, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax 2011;66:49–54
11. 11.Buist AS, Vollmer WM, Sullivan SD, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005;2:277–83
12. 12.Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741–50
 
							 
						